Events on November 09, 2017

Events for this time period have passed. If you need information about a past event, the DOM webmaster may be able to assist you. Please email

Medicine Grand Rounds

What does CRISPR mean for Cardiologists? Bruce Conklin*, MD

Gladstone Scientific Officer, Research Technology & Innovation

Senior Investigator, Gladstone

Professor, UCSF Departments of Medicine and Ophthalmology

Deputy Director, Innovative Genomics Institute

*What is CRISPR?

*What does CRISPR technology mean for understanding disease?

*How can CRISPR technology be used to cure disease?

Dr. Conklin’s research focuses on genome engineering to identify novel therapeutic approaches to human disease. By making precise genetic changes in induced pluripotent cells he seeks to reveal the cellular and molecular mechanisms of disease and identify new methods for therapeutic editing. He began his research career by working for two years at NIH with Julius Axelrod, Ph.D., (Nobel Laureate). He then completed his residency at Johns Hopkins Hospital and a postdoctoral fellowship in the laboratory of Henry Bourne, M.D. at UCSF. In 1995 Dr. Conklin joined the Gladstone Institutes and the UCSF faculty where he is now a Senior Investigator at Gladstone, and a Professor at UCSF. Dr. Conklin is also the Gladstone Scientific Officer for Technology & Innovation and the deputy director of the Innovative Genomics Institute. He is the founder BayGenomics, GenMAPP, AltAnalyze and WikiPathways. He pioneered the field of chemogenetics using designer GPCRs (RASSLs). He founded the Gladstone Genomics and Stem Cell Cores. He advises multiple organizations including the Allen Institute for Cell Science, Chinese University of Hong Kong, and the SF Exploratorium. He is a Fellow in the California Academy of Sciences and a member the American Society for Clinical Investigation.

*Faculty Relationship Disclosure:

Bruce Conklin, MD, Tenaya Therapeutics – Co-Founder, Advisor, Stock Holder

Switch Bio – Scientific Advisor, Stock Holder – Scientific Advisor, Stock Holder

Cellogy, Inc. – Scientific Advisor, Stock Holder
HSW-300 + Add to calendar

Cath Lab Conference

Presentation will be given by Alan Baik M-1179 + Add to calendar